Abstract Development of tau-based therapies for Alzheimer’s disease requires an understanding
of the timing of disease-related changes in tau. We quantified the phosphorylation state …

OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants
who were collected across several ongoing studies in the Washington University Knight …

Alzheimer’s disease (AD) is characterized by two molecular pathologies: cerebral β-amyloidosis
in the form of β-amyloid (Aβ) plaques and tauopathy in the form of neurofibrillary tangles…

A deficit in empathy has consistently been cited as a central characteristic of Asperger syndrome
(AS), but previous research on adults has predominantly focused on cognitive empathy, …

Individualizing patient treatment is a core objective of the medical field. Reaching this
objective has been elusive owing to the complex set of factors contributing to both disease and …

Introduction This meta-analysis aimed to characterize the nature and magnitude of amyloid (Aβ)-related
cognitive impairment and decline in cognitively normal (CN) older individuals. …

Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers (…

In the present study we introduce a sensitive video-based test for the evaluation of subtle
mindreading difficulties: the Movie for the Assessment of Social Cognition (MASC). This new …

Dominantly inherited Alzheimer’s disease (DIAD) causes predictable biological changes
decades before the onset of clinical symptoms, enabling testing of interventions in the …

Background Models of Alzheimer's disease propose a sequence of amyloid β (Aβ) accumulation,
hypometabolism, and structural decline that precedes the onset of clinical dementia. …